2-(4-Methylpiperazin-1-yl)ethanamine trihydrochloride, 95.0%, 2.5g

(R)-[2,3':1',1'':3'',2'''-Quaternaphthalene]-2',2''-diol, 97%, 250mg

2-Aminopyridine-4-methanol, 98.0%, 5g

3-(DIFLUOROMETHYL)CYCLOBUTANONE, 95.0%, 500mg

(2-Aminopyrimidin-5-yl)boronic acid, 95.0%, 50g

4-Bromo-5-isopropyl-1H-pyrazole, 95.0%, 5g

5-Fluoro-6-hydroxy-2-methyl-4(1H)-pyrimidinone, 95.0%, 5g

Acid-PEG4-S-S-PEG4-acid, 250mg

N-Carbobenzoxy-N-methylglycine>97.0%(HPLC)25g

1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one, 95.0%, 250mg

Long working distance plan Fluarex 40x/0.65 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

4-(4-Methylbenzoyl)-1H-pyrrole-2-carboxylic acid, 95%, 1g

2,2'-(2,5-Difluoro-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 97%, 10g